Annual D&A
$26.14 M
-$6.52 M-19.96%
31 December 2023
Summary:
Fulgent Genetics annual depreciation & amortization is currently $26.14 million, with the most recent change of -$6.52 million (-19.96%) on 31 December 2023. During the last 3 years, it has risen by +$23.18 million (+782.61%). FLGT annual D&A is now -19.96% below its all-time high of $32.66 million, reached on 31 December 2022.FLGT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$5.92 M
-$233.00 K-3.79%
30 September 2024
Summary:
Fulgent Genetics quarterly depreciation & amortization is currently $5.92 million, with the most recent change of -$233.00 thousand (-3.79%) on 30 September 2024. Over the past year, it has dropped by -$499.00 thousand (-7.77%). FLGT quarterly D&A is now -39.71% below its all-time high of $9.82 million, reached on 30 September 2022.FLGT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$25.27 M
-$499.00 K-1.94%
30 September 2024
Summary:
Fulgent Genetics TTM depreciation & amortization is currently $25.27 million, with the most recent change of -$499.00 thousand (-1.94%) on 30 September 2024. Over the past year, it has dropped by -$4.14 million (-14.09%). FLGT TTM D&A is now -27.48% below its all-time high of $34.85 million, reached on 31 March 2023.FLGT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.0% | -7.8% | -14.1% |
3 y3 years | +782.6% | +86.6% | +192.6% |
5 y5 years | +1108.7% | +1076.9% | +1110.8% |
FLGT Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -20.0% | +782.6% | -39.7% | +86.6% | -27.5% | +192.6% |
5 y | 5 years | -20.0% | +1140.8% | -39.7% | +1076.9% | -27.5% | +1110.8% |
alltime | all time | -20.0% | >+9999.0% | -39.7% | +2874.9% | -27.5% | >+9999.0% |
Fulgent Genetics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.92 M(-3.8%) | $25.27 M(-1.9%) |
June 2024 | - | $6.15 M(-7.7%) | $25.77 M(-0.6%) |
Mar 2024 | - | $6.66 M(+2.0%) | $25.93 M(-0.8%) |
Dec 2023 | $26.14 M(-20.0%) | $6.53 M(+1.8%) | $26.14 M(-11.1%) |
Sept 2023 | - | $6.42 M(+1.7%) | $29.41 M(-10.4%) |
June 2023 | - | $6.31 M(-8.2%) | $32.81 M(-5.8%) |
Mar 2023 | - | $6.88 M(-29.8%) | $34.85 M(+6.7%) |
Dec 2022 | $32.66 M(+196.8%) | $9.80 M(-0.2%) | $32.66 M(+23.9%) |
Sept 2022 | - | $9.82 M(+17.7%) | $26.35 M(+33.7%) |
June 2022 | - | $8.35 M(+77.7%) | $19.70 M(+43.0%) |
Mar 2022 | - | $4.70 M(+34.5%) | $13.78 M(+25.2%) |
Dec 2021 | $11.00 M(+271.5%) | $3.49 M(+10.0%) | $11.00 M(+27.4%) |
Sept 2021 | - | $3.17 M(+31.2%) | $8.63 M(+39.6%) |
June 2021 | - | $2.42 M(+25.8%) | $6.18 M(+43.3%) |
Mar 2021 | - | $1.92 M(+71.3%) | $4.32 M(+45.7%) |
Dec 2020 | $2.96 M | $1.12 M(+55.4%) | $2.96 M(+23.5%) |
Sept 2020 | - | $722.00 K(+31.5%) | $2.40 M(+10.1%) |
June 2020 | - | $549.00 K(-3.5%) | $2.18 M(+1.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $569.00 K(+2.0%) | $2.14 M(+1.6%) |
Dec 2019 | $2.11 M(-2.6%) | $558.00 K(+10.9%) | $2.11 M(+1.0%) |
Sept 2019 | - | $503.00 K(-1.6%) | $2.09 M(-2.1%) |
June 2019 | - | $511.00 K(-4.5%) | $2.13 M(-2.3%) |
Mar 2019 | - | $535.00 K(-0.6%) | $2.18 M(+0.9%) |
Dec 2018 | $2.16 M(+25.2%) | $538.00 K(-1.6%) | $2.16 M(+3.1%) |
Sept 2018 | - | $547.00 K(-2.7%) | $2.10 M(+5.5%) |
June 2018 | - | $562.00 K(+8.9%) | $1.99 M(+8.6%) |
Mar 2018 | - | $516.00 K(+9.1%) | $1.83 M(+6.0%) |
Dec 2017 | $1.73 M(+47.7%) | $473.00 K(+8.0%) | $1.73 M(+3.2%) |
Sept 2017 | - | $438.00 K(+8.1%) | $1.68 M(+8.8%) |
June 2017 | - | $405.00 K(-1.7%) | $1.54 M(+11.4%) |
Mar 2017 | - | $412.00 K(-1.9%) | $1.38 M(+18.2%) |
Dec 2016 | $1.17 M(+103.5%) | $420.00 K(+38.6%) | $1.17 M(+56.0%) |
Sept 2016 | - | $303.00 K(+22.2%) | $750.00 K(+67.8%) |
June 2016 | - | $248.00 K(+24.6%) | $447.00 K(+124.6%) |
Mar 2016 | - | $199.00 K | $199.00 K |
Dec 2015 | $575.00 K(+193.4%) | - | - |
Dec 2014 | $196.00 K | - | - |
FAQ
- What is Fulgent Genetics annual depreciation & amortization?
- What is the all time high annual D&A for Fulgent Genetics?
- What is Fulgent Genetics annual D&A year-on-year change?
- What is Fulgent Genetics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Fulgent Genetics?
- What is Fulgent Genetics quarterly D&A year-on-year change?
- What is Fulgent Genetics TTM depreciation & amortization?
- What is the all time high TTM D&A for Fulgent Genetics?
- What is Fulgent Genetics TTM D&A year-on-year change?
What is Fulgent Genetics annual depreciation & amortization?
The current annual D&A of FLGT is $26.14 M
What is the all time high annual D&A for Fulgent Genetics?
Fulgent Genetics all-time high annual depreciation & amortization is $32.66 M
What is Fulgent Genetics annual D&A year-on-year change?
Over the past year, FLGT annual depreciation & amortization has changed by -$6.52 M (-19.96%)
What is Fulgent Genetics quarterly depreciation & amortization?
The current quarterly D&A of FLGT is $5.92 M
What is the all time high quarterly D&A for Fulgent Genetics?
Fulgent Genetics all-time high quarterly depreciation & amortization is $9.82 M
What is Fulgent Genetics quarterly D&A year-on-year change?
Over the past year, FLGT quarterly depreciation & amortization has changed by -$499.00 K (-7.77%)
What is Fulgent Genetics TTM depreciation & amortization?
The current TTM D&A of FLGT is $25.27 M
What is the all time high TTM D&A for Fulgent Genetics?
Fulgent Genetics all-time high TTM depreciation & amortization is $34.85 M
What is Fulgent Genetics TTM D&A year-on-year change?
Over the past year, FLGT TTM depreciation & amortization has changed by -$4.14 M (-14.09%)